Correlation Between Morgan Stanley and Elicio Therapeutics

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley and Elicio Therapeutics, you can compare the effects of market volatilities on Morgan Stanley and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Elicio Therapeutics.

Diversification Opportunities for Morgan Stanley and Elicio Therapeutics

0.47

Correlation Coefficient

Morgan Stanley  Elicio Therapeutics

Very weak diversification

The 3 months correlation between Morgan and Elicio is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between Morgan Stanley and Elicio Therapeutics

Allowing for the 90-day total investment horizon Morgan Stanley is expected to generate 0.2 times more return on investment than Elicio Therapeutics. However, Morgan Stanley is 4.93 times less risky than Elicio Therapeutics. It trades about -0.18 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  13,378  in Morgan Stanley on September 17, 2024 and sell it today you would lose (475.00) from holding Morgan Stanley or give up 3.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Morgan Stanley  vs.  Elicio Therapeutics

Morgan Stanley

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Morgan Stanley unveiled solid returns over the last few months and may actually be approaching a breakup point.

Elicio Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morgan Stanley and Elicio Therapeutics

The main advantage of trading using opposite Morgan Stanley and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.

The idea behind Morgan Stanley and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.